This Article Full Text (PDF) Other Versions of this Article: MCB.00305-08v1 28/19/5951    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Google Scholar Articles by Rosenbluth, J. M. Articles by Pietenpol, J. A. PubMed PubMed Citation Articles by Rosenbluth, J. M. Articles by Pietenpol, J. A.

 Previous Article  |  Next Article 

Mol. Cell. Biol. doi:10.1128/MCB.00305-08
Copyright (c) 2008, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

A gene signature-based approach identifies mTOR as a regulator of p73

From the Department of Biochemistry, Center in Molecular Toxicology, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN USA 37232

^* To whom correspondence should be addressed. Email: j.pietenpol{at}vanderbilt.edu.

	Abstract

Although genomic technologies have advanced the characterization of gene regulatory networks downstream of transcription factors, the identification of pathways upstream of these transcription factors has been more challenging. In this study we present a gene signature-based approach for connecting signaling pathways to transcription factors, as exemplified by p73. We generated a p73 gene signature by integrating whole-genome chromatin immunoprecipitation and expression profiling. The p73 signature was linked to corresponding signatures produced by drug candidates, using the in silico Connectivity Map resource, to identify drugs that would induce p73 activity. Of the pharmaceutical agents identified, there was enrichment for direct or indirect inhibitors of mammalian Target of Rapamycin (mTOR) signaling. Treatment of both primary cells and cancer cell lines with rapamycin, metformin, and pyrvinium resulted in an increase in p73, as did RNAi-mediated knockdown of mTOR. Further, a subset of genes associated with insulin response or autophagy exhibited mTOR-mediated, p73-dependent expression. Thus, downstream gene signatures can be used to identify upstream regulators of transcription factor activity, and doing so, we identified a new link between mTOR, p73, and p73-regulated genes associated with autophagy and metabolic pathways.